These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24753022)

  • 1. HBV reactivation in immunosuppressed patients: prevention or containment?
    Ludwig E
    Hepatology; 2014 Jun; 59(6):2062-4. PubMed ID: 24753022
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk of reactivation of hepatitis B in patients with the lymphoma HBsAg negative , anti-HBc positive treated with rituximab-CHOP].
    Pariente A
    Rev Prat; 2014 Mar; 64(3):324. PubMed ID: 24851363
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
    Hsu C; Tsou HH; Lin SJ; Wang MC; Yao M; Hwang WL; Kao WY; Chiu CF; Lin SF; Lin J; Chang CS; Tien HF; Liu TW; Chen PJ; Cheng AL;
    Hepatology; 2014 Jun; 59(6):2092-100. PubMed ID: 24002804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy.
    Kusumoto S; Tanaka Y; Mizokami M; Ueda R
    Hepatology; 2014 Aug; 60(2):765-6. PubMed ID: 24347499
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply: To PMID 24002804.
    Hsu C; Chen PJ; Cheng AL
    Hepatology; 2014 Aug; 60(2):766-7. PubMed ID: 24310720
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.
    Niitsu N; Hagiwara Y; Tanae K; Kohri M; Takahashi N
    J Clin Oncol; 2010 Dec; 28(34):5097-100. PubMed ID: 20837949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectiveness.
    Hay AE; Meyer RM
    J Clin Oncol; 2012 Sep; 30(26):3155-7. PubMed ID: 22891267
    [No Abstract]   [Full Text] [Related]  

  • 8. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
    Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
    JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism at
    Bashash M; Connors JM; Gascoyne RD; Meissner B; Schuetz JM; Leach S; Slack GW; Berry BR; Hu H; Sehn LH; Brooks-Wilson AR; Spinelli JJ
    Haematologica; 2017 May; 102(5):e199-e202. PubMed ID: 28154089
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
    Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
    Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis.
    Zurawska U; Hicks LK; Woo G; Bell CM; Krahn M; Chan KK; Feld JJ
    J Clin Oncol; 2012 Sep; 30(26):3167-73. PubMed ID: 22711851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
    Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hope for very elderly patients with diffuse large B-cell lymphoma.
    Ribera JM
    Lancet Oncol; 2011 May; 12(5):412-3. PubMed ID: 21482185
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative dose intensity of R-CHOP therapy and patient outcomes in advanced follicular lymphoma.
    Konishi T; Kanemasa Y; Sasaki Y; Okuya T; Yamaguchi T; Funasaka C; Shimoyama T; Omuro Y
    Hematol Oncol; 2019 Aug; 37(3):303-307. PubMed ID: 30933366
    [No Abstract]   [Full Text] [Related]  

  • 15. Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.
    Gopal AK; Kahl BS; Flowers CR; Martin P; Ansell SM; Abella-Dominicis E; Koh B; Ye W; Barr PM; Salles GA; Friedberg JW
    Blood; 2017 Jun; 129(22):3037-3039. PubMed ID: 28325864
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.
    Li X; Lin Q; Dong M; Wen JY; Wei L; Ma XK; Chen ZH; Wu XY
    Leuk Lymphoma; 2010 Sep; 51(9):1678-85. PubMed ID: 20807095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance).
    Witzig TE; LaPlant B; Habermann TM; McPhail E; Inwards DJ; Micallef IN; Colgan JP; Nowakowski GS; Ansell SM; Johnston PB
    Blood Cancer J; 2017 Jun; 7(6):e576. PubMed ID: 28649983
    [No Abstract]   [Full Text] [Related]  

  • 18. Hidden superpower.
    McGuirt J
    JAAPA; 2019 May; 32(5):66. PubMed ID: 31033720
    [No Abstract]   [Full Text] [Related]  

  • 19. A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?
    Tadmor T; McLaughlin P; Polliack A
    Leuk Lymphoma; 2010 May; 51(5):737-8. PubMed ID: 20367567
    [No Abstract]   [Full Text] [Related]  

  • 20. Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
    Oki Y; Ewer MS; Lenihan DJ; Fisch MJ; Hagemeister FB; Fanale M; Romaguera J; Pro B; Fowler N; Younes A; Astrow AB; Huang X; Kwak LW; Samaniego F; McLaughlin P; Neelapu SS; Wang M; Fayad LE; Durand JB; Rodriguez MA
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):152-8. PubMed ID: 25445468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.